期刊文献+

MKK4基因启动子区-1044A>T多态与鼻咽癌易感性的研究 被引量:2

Research of association between functional polymorphism(1044A>T)in the MKK4 gene and the susceptivity of nasopharyngeal carcinoma
下载PDF
导出
摘要 目的 探讨MKK4基因启动子区-1044A〉T位点单核苷酸多态基因型与散发性鼻咽癌遗传易感性的关系。方法采用聚合酶链反应-限制性片段长度多态性法(PCR-RFLP)检测30例健康人和90例鼻咽癌患者的MKK4基因-1044A〉T位点(rs3809728)单核苷酸多态性。结果 MKK4基因-1044A〉T位点基因多态性在病例组和对照组中分布差异无统计学意义,AT基因型(OR=0.726,95%CI=0.333-2.151),TT基因型(OR=0.952,95%CI=0.094-9.663),P=0.712。结论 MKK4基因-1044A〉T位点的单核苷酸多态性:可能与散发性鼻咽癌易感性无关。 Objective To investigate the association between the functional polymorphism(1044A〉T) of the MKK4 gene and the genetic susceptibility of sporadic nasopharyngeal carcinoma. Methods Detected the mononocletide polymorphism of MKK4 cinoma by using polymerase chain reaction-restric- gene (1044A〉T) in 30 healthy people and 90 patients with nasopharyngeal carcinoma by using polymerase chain reaction-restrietion fragment length polymorphism(PCR-RFLP) Results There was no statistical sighificance of the MKK4 gene (1044A〉T)between experimental and control group(AT: OR=0.726,95% CI, 0.333 0:094-9. 663, P =0. 712). Conclusion Mononocletide polymorphism of MKK4 gene (1044A〉T) may not relate to the susceptibility of sporadic nasopharyngeal carcinoma.
出处 《重庆医学》 CAS 北大核心 2015年第34期4793-4795,共3页 Chongqing medicine
基金 湖北省自然基金资助项目(2014CFB675) 湖北省教育厅重点基金资助项目(D20141205) 2012年宜昌市科技研究与开发基金(A12301-03)
关键词 鼻咽肿瘤 MKK4 多态性 单核苷酸 nasopharyngeal neoplasms MKK4 polymorphisms, single
  • 相关文献

参考文献15

  • 1Chen L, H u CS, Chen XZ, et al. Concurrent chemoi-adiother-rapy plus adjuvant chemotherapy versus cencurrent chemo-therapy alone in patients with locoregionally advanced naso-pharyngeal carcinoma: a pi us 3 multi centre randornised con-trolled trial[J]. Lancet Oncol,2012,13(2) :163-171.
  • 2Zhou Xv CuiJ,Macias Vv et al. The progress on genetic analysis of nasopharyngeal caicinomay[J]. Comp Funct Ge-nomics,2007 :57513.
  • 3Dong x.u Y,Du Mvet al. P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model[J]. EurJ Cardiothorac Surg, 2006,30(1) : 77-84.
  • 4鲁明骞,孔庆志.丝裂原活化蛋白激酶信号传导通路在恶性肿瘤中的研究现状[J].实用癌症杂志,2013,28(3):320-321. 被引量:9
  • 5Cheng YJ, Lee CH, Lin YP, et al. Caspase-3 enhances lung metastasis and cell migration in a protease-independent mechanism through the ERK pathway[J]. IntJ Canc-er,2008,123(6):1278-1285.
  • 6鲁明骞,许新华.MKK4与恶性肿瘤相关性的研究进展[J].山东医药,2011,51(19):110-111. 被引量:6
  • 7Spillman MA,LacyJ ,Murphy SK,et al. Regulation of the metastasis suppressor gene MKK4 in ovarian cancerJ J], Gynecol Oncol,2007 ,105(2) :312-320.
  • 8Sousa H, Pando M, Breda E, et al. Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma[J]. Mol Carcinog, 2011,50(2) :73-79.
  • 9XU YF, Liu WL, DongJQ, et al. Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese[J]. BMC Med Genet,2010,l1:161.
  • 10Farhat K, Hassen E, Bouzgarrou N, et al. Functional IL- 18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients[J]. Cytokine , 2008,43 (2): 132-137.

二级参考文献39

  • 1Lin A, Minden A, Martinetto H, et al. Identification of a dual apecificity kinase that activates the Jun kinases and p38,Mpk2[J]. Science, 1995,268(5208) : 286-290.
  • 2Sanchez I, Hughes RT, Barrett T, et al. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating the transcription factor c-Jun[ J]. Nature, 1994,372 (6508) :794-798.
  • 3Derijard B, Raingeaud J, Barrett T, et al. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms[ J]. Science, 1995,267 (5198) :682-685.
  • 4Toumier C, Whitmarsh AT, Cavanagh J, et al. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kina[J]. Proc Natl Acad Sci USA, 1997, 94(14) :7337-7342.
  • 5Minden A, Lin A, McMahon M, et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK[J]. Science, 1994, 266(5191) :1719-1723.
  • 6Minden A, Lin A, Smeal T, et al. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogvn-acfivated protein kinases [ J ]. Mol Cell Biol, 1994,14 (10) :6683-6688.
  • 7Raingeaud J, Whitmarsh KI, Barrett T, et al. MKK3- and MKK6- regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway[J]. Mol Cell Biol, 1996,16 (3) : 1247-1255.
  • 8Yeasmin S, Nakayama K, Rahman MT, et al. Loss of MKK4 expression in ovarian cancer: A potential role for the epithelial to mesenchymal transition[J]. Int J Cancer, 2010,128(1) :94-104.
  • 9Wu CW, Li AF, Chi CW, et al. Human gastric cancer kinase profile and prognostic significance d MKK4 kinase [ J ]. Am J Pathol, 2000, 156(6) :2007-2015.
  • 10Lotan TL, Lyon M, Huo D, et al. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia [ J]. J Pathd, 2007,212 (4) :386-394.

共引文献11

同被引文献24

  • 1Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherrapy plus adjuvant chemotherapy versus cencurrent chemotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: A plus 3 multicentre randomised controlled trial [ J ]. Lancet On- col, 2012,13(2) :163-171.
  • 2Taylor JL, Szmulewitz RZ, Lotan T, et al. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer ceils[ J]. Cancer Lett, 2008,272( 1 ) :12-22.
  • 3Tang KF, Tan SY, Chan SH, et al. A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implica-tion for the intense tumor infiltration by T lymphocytes and macro- phages[ J]. Hum Pathol, 2001,32( 1 ) :42-49.
  • 4Whitmarsh A J, Davis RJ. Role of mitogen-activated protein kinase kinase 4 incaneer[J]. Oncogene, 2007,26(22) :3172-3184.
  • 5Wuestefeld T, Pesic M, Rudalska R, et al. A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration[ J]. Cell, 2013,153(2) :389-401.
  • 6An J, Liu H, Magyar CE, et al. Hyperactivated JNK is a thera- peutic target in pVHL-deficient renal cell carcinoma [ J ]. Cancer Res, 2013,73 (4) : 1374-1385.
  • 7Khamis ZI, Iczkowski KA, Sang QX. Metastasis suppressors in hu- man benign prostate, intraepithelial neoplasia, and invasive canc- er: their prospects as therapeutic agents[ J]. Med Res Rev, 2012, 32(5 ) : 1026-1077.
  • 8Divya SP, Wang X, Pratheeshkumar P, et al. Blackberry extract inhibits UVB-induced oxidative damage and inflammation through MAP kinases and NF-κB signaling pathways in SKH-1 mice skin [ J]. Son YOToxicol Appl Pharmacol, 2015,284( 1 ) :92-99.
  • 9Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD) [J]. Lancet Oncol, 2008,9(8) :730-756.
  • 10Bozdogan O, Yulug IG, Vargel I, et al. Differential expression patterns of metastasis suppressor proteins in basal cell carcinoma [J]. Int J Dermatol, 2015,54(8) :905-915.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部